Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 1
2013 1
2014 1
2016 4
2017 4
2018 1
2019 1
2020 1
2021 4
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M; the New Technology for Cervical Cancer 2 Working Group. Giorgi Rossi P, et al. Among authors: passamonti b. J Natl Cancer Inst. 2021 Mar 1;113(3):292-300. doi: 10.1093/jnci/djaa105. J Natl Cancer Inst. 2021. PMID: 32745170 Free PMC article.
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
Gustinucci D, Benevolo M, Cesarini E, Mancuso P, Passamonti B, Giaimo MD, Corvetti R, Nofrini V, Bulletti S, Malaspina M, Tintori B, Giorgi Rossi P; Umbria HPV Screening Working Group. Gustinucci D, et al. Among authors: passamonti b. Int J Cancer. 2022 Mar 15;150(6):952-960. doi: 10.1002/ijc.33858. Epub 2021 Nov 5. Int J Cancer. 2022. PMID: 34706093 Free article.
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.
Giorgi Rossi P, Ronco G, Mancuso P, Carozzi F, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Venturelli F, Benevolo M; NTCC2 Working Group. Giorgi Rossi P, et al. Among authors: passamonti b. Int J Cancer. 2022 Oct 1;151(7):1047-1058. doi: 10.1002/ijc.34120. Epub 2022 Jun 7. Int J Cancer. 2022. PMID: 35579975 Free article. Clinical Trial.
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Benevolo M, et al. Cancer Cytopathol. 2021 May;129(5):383-393. doi: 10.1002/cncy.22385. Epub 2020 Nov 3. Cancer Cytopathol. 2021. PMID: 33142029 Free article.
Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix.
Gustinucci D, Ciccocioppo L, Coppola L, Negri G, Zannoni G, Passamonti B, Cesarini E, Ianzano C, Andreano T, Pireddu A, Giorgi-Rossi P. Gustinucci D, et al. Among authors: passamonti b. Diagnostics (Basel). 2021 Mar 30;11(4):619. doi: 10.3390/diagnostics11040619. Diagnostics (Basel). 2021. PMID: 33808260 Free PMC article.
Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.
Benevolo M, Allia E, Gustinucci D, Rollo F, Bulletti S, Cesarini E, Passamonti B, Giovagnoli MR, Carico E, Carozzi FM, Mongia A, Fantacci G, Confortini M, Rubino T, Fodero C, Prandi S, Marchi N, Farruggio A, Coccia A, Macrì L, Ghiringhello B, Ronco G, Bragantini E, Polla E, Maccallini V, Negri G, Giorgi Rossi P; New Technologies for Cervical Cancer Screening 2 (NTCC2) Working Group. Benevolo M, et al. Among authors: passamonti b. Cancer Cytopathol. 2017 Mar;125(3):212-220. doi: 10.1002/cncy.21800. Epub 2016 Dec 7. Cancer Cytopathol. 2017. PMID: 27926800 Free article.
Guidance for faecal occult blood testing: quantitative immunochemical method (FIT-HB) in colorectal cancer screening programmes.
Rubeca T, Rapi S, Deandrea S, Malaspina M, Passamonti BU, Grassi E, Cioccarelli AM, Marchetti E, Boni M, Cellai F, Pradella M, Gattafoni F, Rotolo S. Rubeca T, et al. Among authors: passamonti bu. Epidemiol Prev. 2017 Sep-Dec;41(5-6 (Suppl 1)):1-31. doi: 10.19191/EP17.5-6S1.P001.101. Epidemiol Prev. 2017. PMID: 29129048 Free article. English, Italian.
A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
Passamonti B, Malaspina M, Fraser CG, Tintori B, Carlani A, D'Angelo V, Galeazzi P, Di Dato E, Mariotti L, Bulletti S, D'Amico MR, Gustinucci D, Martinelli N, Spita N, Cesarini E, Rubeca T, Giaimo M, Segnan N, Senore C. Passamonti B, et al. Gut. 2018 Mar;67(3):485-496. doi: 10.1136/gutjnl-2016-312716. Epub 2016 Dec 14. Gut. 2018. PMID: 27974550 Clinical Trial.
Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
Gustinucci D, Giorgi Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A, D'angelo V, D'amico MR, Di Dato E, Galeazzi P, Malaspina M, Martinelli N, Spita N, Tintori B, Giaimo MD, Passamonti B. Gustinucci D, et al. Among authors: passamonti b. Am J Clin Pathol. 2016 Jan;145(1):35-45. doi: 10.1093/ajcp/aqv019. Am J Clin Pathol. 2016. PMID: 26712869
17 results